- Home
- EHGO vs EOLS Comparison
EHGO vs EOLS Comparison
Compare EHGO & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHGO
- EOLS
- Stock Information
- Founded
- EHGO 2015
- EOLS 2012
- Country
- EHGO China
- EOLS United States
- Employees
- EHGO N/A
- EOLS N/A
- Industry
- EHGO
- EOLS Biotechnology: Pharmaceutical Preparations
- Sector
- EHGO
- EOLS Health Care
- Exchange
- EHGO NYSE
- EOLS Nasdaq
- Market Cap
- EHGO 23.0M
- EOLS 589.3M
- IPO Year
- EHGO 2024
- EOLS 2018
- Fundamental
- Price
- EHGO $0.78
- EOLS $9.27
- Analyst Decision
- EHGO
- EOLS Strong Buy
- Analyst Count
- EHGO 0
- EOLS 5
- Target Price
- EHGO N/A
- EOLS $23.75
- AVG Volume (30 Days)
- EHGO 3.3M
- EOLS 857.3K
- Earning Date
- EHGO 07-29-2025
- EOLS 07-30-2025
- Dividend Yield
- EHGO N/A
- EOLS N/A
- EPS Growth
- EHGO N/A
- EOLS N/A
- EPS
- EHGO N/A
- EOLS N/A
- Revenue
- EHGO $15,393,105.00
- EOLS $275,463,000.00
- Revenue This Year
- EHGO N/A
- EOLS $33.39
- Revenue Next Year
- EHGO N/A
- EOLS $33.21
- P/E Ratio
- EHGO N/A
- EOLS N/A
- Revenue Growth
- EHGO N/A
- EOLS 25.38
- 52 Week Low
- EHGO $0.71
- EOLS $8.67
- 52 Week High
- EHGO $5.50
- EOLS $17.82
- Technical
- Relative Strength Index (RSI)
- EHGO N/A
- EOLS 44.53
- Support Level
- EHGO N/A
- EOLS $9.10
- Resistance Level
- EHGO N/A
- EOLS $9.95
- Average True Range (ATR)
- EHGO 0.00
- EOLS 0.36
- MACD
- EHGO 0.00
- EOLS 0.05
- Stochastic Oscillator
- EHGO 0.00
- EOLS 28.42
About EHGO ESHALLGO INC
Eshallgo Inc. focuses on two distinct market sectors: office supply sale and leasing, and after-sale maintenance and repair. It is an authorized distributor of brands of office equipment, including HP, Epson, Xerox, Sharp, Toshiba, Konica, Kyocera, and other brands.
About EOLS Evolus Inc.
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.